Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Comment by bball67on Jun 30, 2022 12:38pm
173 Views
Post# 34794178

RE:RE:RE:RE:RE:RE:RE:Series 1 Shares - 70million Consolidable or not

RE:RE:RE:RE:RE:RE:RE:Series 1 Shares - 70million Consolidable or notMole and Farmer, I can confirm that there are two men dressed and acting like clowns at the corporate headquarters. They were staring at a giant curtain at the front of the auditorium. There was a giant crystal ball on a table. I was told the Boston Group wizard was behind the curtain. He began shouting orders to the clowns and employees, "the fix is in" and "steal more shares". He repeated this many times with an echo to his voice. The clowns were nodding their heads in agreement. This was an out of body experience for me. It is not a conspiracy theory, it is true that there are clowns at the headquarters but the Boston Wizard is in control. This has changed forever my thoughts about Promis. At the end, the Wizard called out my name, "Bball, we want to steal your shares". That was freaky. He continued, "do you think we want dilution of our shares?". Before I could answer, he said, "No". "We just want to cure people of Alzheimers". The Clowns and I were told by a voice coming out of the crystal ball, "there will be amazingly good and positive news ahead". Wow, what a trip.
<< Previous
Bullboard Posts
Next >>